A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection
Status:
Completed
Trial end date:
2008-12-17
Target enrollment:
Participant gender:
Summary
This study will involve the use of a new medicine called GW642444 being developed for the
treatment of asthma and chronic obstructive pulmonary disease (COPD). The purpose of the
study is to see how safe and how well tolerated the study drug is when it is given as a
liquid by mouth or by injection into a vein. In addition the study will measure how much of
the medicine gets into the bloodstream when it is given by mouth, by injection into a vein
and inhaled, and how long the body takes to get rid of it.